Callahan Advisors’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.26M Sell
2,912
-160
-5% -$48.6K 0.1% 111
2026
Q1
$656K Buy
3,072
+4
+0.1% +$894 0.05% 129
2025
Q4
$525K Buy
3,068
+113
+4% +$17.6K 0.04% 135
2025
Q3
$396K Buy
2,955
+105
+4% +$11.1K 0.03% 132
2025
Q2
$277K Buy
+2,850
New +$226K 0.02% 143
2024
Q4
Sell
-2,730
Closed -$222K 169
2024
Q3
$222K Buy
2,730
+10
+0.4% +$869 0.02% 136
2024
Q2
$290K Buy
2,720
+100
+4% +$9.59K 0.03% 127
2024
Q1
$255K Hold
2,620
0.03% 128
2023
Q4
$205K Buy
+2,620
New +$179K 0.02% 137
2022
Q1
Sell
-3,070
Closed -$221K 150
2021
Q4
$221K Buy
+3,070
New +$192K 0.02% 144

Other funds holding LRCX

Callahan Advisors's LRCX Position: Q2 2026 in Review

Callahan Advisors reduced its Lam Research (LRCX) stake by 5.2% in Q2 2026, selling an estimated $48.6K and leaving 2,912 shares worth $1.26M. The position accounts for 0.1% of the portfolio, ranked #111.

Callahan Advisors first reported a position in LRCX in Q4 2021 and has held it in 10 quarters since. 1,507 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Callahan Advisors held 2,912 shares of Lam Research worth $1.26M as of Q2 2026.
  • Callahan Advisors sold 160 Lam Research shares in Q2 2026, an estimated $48.6K.
  • Lam Research made up 0.1% of Callahan Advisors's portfolio in Q2 2026, its #111 holding.
  • Callahan Advisors first reported a position in Lam Research in Q4 2021 and has held it in 10 quarters since.
  • 1,507 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Callahan Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.